• KEYNOTE SPEAKER 2023

    Stefan Woxström, Senior Vice President, Europe & Canada, AstraZeneca

  • Swiss Nordic Bio 2023

  • High-level networking

    >75 investors and >10 scouting/business development executives from pharma/diagnostic companies are expected at an exclusive event with max. 200 participants in total

  • Pitch your innovation

    Pitch your product & business model to leading investors & pharma and get your innovation to the direct attention of real decision makers

  • 1-on-1 partnering meetings

    Book 1-on-1 meetings online now and meet with your potential partners face-to-face in Zurich - over 400 meetings in one afternoon

  • Funding Opportunities for SMEs

    Switzerland & Sweden regularly launch a "Switzerland-Sweden Call for R&D Project Outlines" within the EUREKA and Eurostars programs. Read more here.

  • Connecting Healthcare Innovations, Investors and Industry

    This high-level Swiss-Nordic exclusive investement and partnering meeting gathers Europe´s leading executives from biotech, pharmaceutical, medtech and diagnostic companies as well as investors from Switzerland and the Nordic countries

  • FIRESIDE CHAT SWISS NORDIC BIO 2022

    With Per Falk, President at Ferring Pharmaceuticals

  • KEYNOTE SPEAKER 2021

    Mikael Dolsten M.D., Ph.d. Chief Scientific Officer and President, Worldwide Research, Development and Medical of Pfizer

SWISS NORDIC BIO 2024

The conference will take place in Zurich in 7 March 2024. 

Swiss Nordic Bio is a high-level partnering and investor conference aimed at connecting healthcare innovations, investor and industry.
  • The conference is the number one platform that gathers life science professionals from Switzerland and the Nordic countries under one roof. 
  • The conference is organised by the Nordic countries in cooperation with Swiss partners.

 

SWISS NORDIC BIO AT A GLANCE

200

participants

60

and more investors

400

one-to-one meetings

40

and more company pitches

CO-HOSTS

PARTNERS

REGISTRATION
LOGIN

IMPORTANT DEADLINES

 

End of registration
28 February 2024


1-to-1 meeting booking open
8 January 2024

 

Event date
7 March 2024

PREVIOUS PARTICIPANTS

Apus Capital
ArchiMed
BB Biotech
Credit Suisse
Eiffel Investment Group
Veraison Capital AG 
Johnson and Johnson Innovation
Novartis Venture Fund
Occident Group
Redalpine Venture Partners
F.Hoffmann-La Roche Ltd
Capital Rewards Partners
Creathor Venture
Management GmbH
Endeavour Vision SA
Merck Ventures BV
Novo A/S (Ventures)
Debiopharm International SA
Lipum AB
Bay City Capital
HBM Partners Ltd.
Industrifonden
MTIP MedTech Innovation Partners AG
PM Equity Partner
Signature Seven Partners
Wille Finance AG
XOventure GmbH
Sunstone Capital
Dottikon Exclusive Synthesis AG

MAIN SPONSOR

IN COOPERATION WITH

MEDIA PARTNERS